tiprankstipranks
Trending News
More News >
MiMedx Group Inc. (MDXG)
:MDXG
US Market
Advertisement

MiMedx Group (MDXG) Stock Statistics & Valuation Metrics

Compare
484 Followers

Total Valuation

MiMedx Group has a market cap or net worth of $1.02B. The enterprise value is $811.92M.
Market Cap$1.02B
Enterprise Value$811.92M

Share Statistics

MiMedx Group has 147,959,410 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding147,959,410
Owned by Insiders2.17%
Owned by Institutions0.01%

Financial Efficiency

MiMedx Group’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 19.67%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)19.67%
Return on Capital Employed (ROCE)0.27
Revenue Per Employee416.82K
Profits Per Employee50.18K
Employee Count837
Asset Turnover1.32
Inventory Turnover2.52

Valuation Ratios

The current PE Ratio of MiMedx Group is 31.9. MiMedx Group’s PEG ratio is -0.84.
PE Ratio31.9
PS Ratio4.05
PB Ratio7.32
Price to Fair Value7.32
Price to FCF21.92
Price to Operating Cash Flow17.00
PEG Ratio-0.84

Income Statement

In the last 12 months, MiMedx Group had revenue of 348.88M and earned 42.42M in profits. Earnings per share was 0.29.
Revenue348.88M
Gross Profit288.81M
Operating Income58.87M
Pretax Income57.29M
Net Income42.42M
EBITDA64.34M
Earnings Per Share (EPS)0.29

Cash Flow

In the last 12 months, operating cash flow was 60.16M and capital expenditures 1.19M, giving a free cash flow of 61.34M billion.
Operating Cash Flow60.16M
Free Cash Flow61.34M
Free Cash Flow per Share0.41

Dividends & Yields

MiMedx Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.81
52-Week Price Change26.36%
50-Day Moving Average6.97
200-Day Moving Average7.20
Relative Strength Index (RSI)60.89
Average Volume (3m)643.57K

Important Dates

MiMedx Group upcoming earnings date is Mar 4, 2026, Before Open (Not Confirmed).
Last Earnings DateOct 29, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date

Financial Position

MiMedx Group as a current ratio of 4.21, with Debt / Equity ratio of 8.52%
Current Ratio4.21
Quick Ratio3.69
Debt to Market Cap0.01
Net Debt to EBITDA-1.24
Interest Coverage Ratio58.51

Taxes

In the past 12 months, MiMedx Group has paid 15.30M in taxes.
Income Tax15.30M
Effective Tax Rate0.27

Enterprise Valuation

MiMedx Group EV to EBITDA ratio is 20.74, with an EV/FCF ratio of 20.68.
EV to Sales3.82
EV to EBITDA20.74
EV to Free Cash Flow20.68
EV to Operating Cash Flow20.16

Balance Sheet

MiMedx Group has $118.87M in cash and marketable securities with $18.46M in debt, giving a net cash position of $100.41M billion.
Cash & Marketable Securities$118.87M
Total Debt$18.46M
Net Cash$100.41M
Net Cash Per Share$0.68
Tangible Book Value Per Share$1.10

Margins

Gross margin is 81.45%, with operating margin of 16.87%, and net profit margin of 12.16%.
Gross Margin81.45%
Operating Margin16.87%
Pretax Margin16.42%
Net Profit Margin12.16%
EBITDA Margin18.44%
EBIT Margin16.71%

Analyst Forecast

The average price target for MiMedx Group is $12.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$12.00
Price Target Upside77.78% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast6.85%
EPS Growth Forecast-67.67%

Scores

Smart Score4
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis